The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence

JAMA Oncology 2026

View at publisher

Authors: Xudong Zhu, Lihui Yan, Xiangyu Zhu, Yue Wang

DOI: 10.1001/jamaoncol.2025.5771

Cited by: 1

References: 7

Abstract

This Viewpoint discusses the ethical implications of Right to Try access to investigational oncology agents for patients and physicians.

Biomedical Ethics and Regulation Ethics in Clinical Research CAR-T cell therapy research

References 7